First-Line Treatment for Lung Cancer

2022-06-24 20:46:14 By : Ms. Susan Song

Oncology Certified Nurse Practitioner and freelance healthcare writer with over a decade of medical oncology and hematology experience.

When you are diagnosed with lung cancer, the preferred initial treatment is called the first-line treatment. It may also be referred to as induction therapy or primary treatment. First-line treatment is usually considered to be the best treatment for the type of cancer diagnosed. It is given first to provide the best outcome.

This article will review the types of lung cancer and the first-line treatments recommended for each.

There are two main types of lung cancer—small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). Knowing the type of lung cancer as well as the stage of the cancer are critical pieces of information the oncologist (a specialist in diagnosing and treating cancer) needs to make treatment decisions. 

Small cell lung cancer begins growing in the cells of the lung, and can quickly grow and begin to spread into other areas of the body, such as the brain, bones, or liver. SCLC tends to be more aggressive than NSCLC. An estimated 13% of newly diagnosed lung cancers are SCLC.  

NSCLC is the most common type of lung cancer, estimated to be over 80% of newly diagnosed lung cancers. NSCLC can be further classified into three subtypes, shown here in order of most to least common:

For both SCLC and NSCLC, first-line treatments may vary depending upon the stage of the cancer. Cancer stage refers to the extent of the cancer (how much is in the body) and how far the cancer has spread in the body, if at all. Cancer is given a stage from 0 (hasn’t spread at all) to stage 4 (has spread to distant areas of the body).  

There are several first-line treatments for lung cancer that may be used individually or in combination with one other. These include:

Surgical removal of the lung tumor and nearby lymph nodes is most often used to treat lung cancer when the tumor is small and unlikely to have spread into nearby tissue. Lung cancer surgery can involve removing only one lobe of the lung or may involve removing an entire lung.

Chemotherapy is medication that kills cancer cells. It works by targeting cells during specific times in their reproductive cycles in order to stop the cells from growing. Different chemotherapy medications work at varying points in a cell cycle. It is considered a systemic therapy as it affects cells throughout the body.

Radiation works by damaging the DNA (hereditary material) inside of the cancer cell so that it is not able to continue to replicate and grow. It's given by a specialized machine that directs beams of radiation to the prescribed area. Radiation is a local therapy, treating only the area where the beam is directed.

Immunotherapy is another systemic treatment for cancer, but works much differently than chemotherapy. It includes various treatments that help the immune system recognize cancer cells and stop their growth or spread. These treatments include:

Some lung cancers have specific mutations (genetic changes) that are partly responsible for the abnormal growth of the cancer cells. Some of these mutations have medications that are available to specifically target them, to help stop or slow the growth of the cancer.

The first-line treatments for SCLC depend upon the stage of the cancer, meaning how far advanced the cancer is. SCLC is categorized as either limited stage or extensive stage. The first-line treatment for limited-stage SCLC can include:

Extensive-stage SCLC may be treated by:

NSCLC treatment is also based upon its stage, ranging from 1 to 4.

The following treatment options can be used for stage 1 NSCLC:

The following treatment options can be used for stage 2 NSCLC:

The following treatment options can be used for stage 3 NSCLC:

Stage 4 NSCLC treatment options include:

Regardless of the type of lung cancer, first-line treatments are given with the expectation that those treatments offer the best chance of curing the cancer or keeping it from growing and spreading. If cancer does not respond to the treatment that was used, different types of treatment or different chemotherapy agents may be needed.

The types of chemotherapy that are used after first-line treatments may not be as effective or work for as long as the initial treatments did. Further testing of the cancer may be needed, such as molecular testing, to see if any targeted therapy can be used.  

Molecular or genomic testing looks at the genes inside cancer cells to identify the presence of biomarkers (substances produced by cancer cells or other cells in response to cancer). Biomarkers are different for each person’s cancer, and if certain biomarkers are present in lung cancer, additional treatment options may be available.

These targeted medications are often not chemotherapy but are medications that target a specific biomarker, affecting how the cancer grows.

Cancer is not the only disease that has first-line treatments. Many chronic illnesses such as diabetes, human immunodeficiency virus (HIV), or heart disease have medications that are best used as before other treatments are tried.

First-line treatments for lung cancer are those given as the initial treatment after diagnosis. The first-line treatments for lung cancer depend upon the stage of the cancer as well as the type. For SCLC, chemotherapy is a standard first-line treatment. For NSCLC, first-line treatment may consist of chemotherapy, radiation and/or surgery. 

Getting a diagnosis of lung cancer can be a time of anxiety and uncertainty. Sometimes it can feel like forever for scans to get done and results to be return, but these these are necessary, as they allow the oncologist to develop the best treatment plan for you.

First-line treatments are the initial treatments chosen because they are expected to provide the biggest benefit in controlling and curing the disease.

The success rate of radiation therapy varies based on the type and stage of lung cancer. But for people with stage 1 NSCLC who can’t have surgery, stereotactic body radiation therapy (SBRT) has been a successful treatment.

The earlier lung cancer is found the more likely it is to have the possibility of cure. For early-stage lung cancers, cure rates can be as high as 80%.

Limiting processed foods and red meats can help ward off cancer risk. These recipes focus on antioxidant-rich foods to better protect you and your loved ones. Sign up and get your guide!

Thank you, {{form.email}}, for signing up.

There was an error. Please try again.

National Cancer Institute. First-line therapy.

American Society of Clinical Oncology. Lung cancer - small cell: introduction.

American Society of Clinical Oncology. Lung cancer - small cell: statistics.

American Society of Clinical Oncology. Lung cancer - non small cell: statistics.

Cancer.net. Lung cancer- non-small cell: introduction.

National Cancer Institute. Cancer staging.

American Lung Association. Lung cancer surgery.

American Cancer Society. How chemotherapy drugs work.

American Cancer Society. How radiation therapy is used to treat cancer.

American Cancer Society. Immune checkpoint inhibitors and their side effects.

American Cancer Society. Targeted therapy.

National Cancer Institute. Small cell lung cancer treatment.

National Cancer Institute. Non-small cell lung cancer treatment.

National Cancer Institute. Biomarker testing for cancer treatment.

Tandberg DJ, Tong BC, Ackerson BG, Kelsey CR. Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review. Cancer. 2018;124(4):667-678. doi:10.1002/cncr.31196

American Society of Clinical Oncology. Just diagnosed with lung cancer: answers from an expert.

Thank you, {{form.email}}, for signing up.

There was an error. Please try again.